Anna Nijdam
Comptroller/Controller/Auditor en PHARVARIS N.V. .
Fortuna: 1 M $ al 30/04/2024
Origen de la red de primer grado Anna Nijdam.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 | |
Entrepreneurs Foundation
 Entrepreneurs Foundation Miscellaneous Commercial ServicesCommercial Services Entrepreneurs Foundation provides privately held companies expert advice on corporate social responsibility and philanthropy. The company was founded in 1998 and is headquartered in Mountain View, CA.
9
| Non-Profit Organization | Miscellaneous Commercial Services | 9 |
Ernst & Young Accountants LLP /Netherlands/
 Ernst & Young Accountants LLP /Netherlands/ Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young Accountants LLP/Netherlands is a company based in Amsterdam, Netherlands. The Dutch company provides accounting, auditing, and bookkeeping services.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anna Nijdam a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder Founder Director/Board Member Chairman Director/Board Member Founder Director/Board Member Founder | |
Silicon Valley Community Foundation
 Silicon Valley Community Foundation Investment Trusts/Mutual FundsMiscellaneous Silicon Valley Community Foundation (SVCF) is an independent community foundation headquartered in Mountain View, California. Founded in 2007, the firm advances innovative philanthropic solutions to challenging problems. SVCF engages donors and corporations from around Silicon Valley, the country, and the globe to make the region and world better for all. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Human Resources Officer Chief Investment Officer | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| VICORE PHARMA HOLDING AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Kosa Pharma GmbH | Founder Founder | ||
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Rfidcompare Europe AB | Director/Board Member | ||
Van Lanschot Kempen Wealth Management NV
 Van Lanschot Kempen Wealth Management NV Investment Banks/BrokersFinance Part of Van Lanschot Kempen NV, Van Lanschot Kempen Wealth Management NV provides investment banking services. The company is based in 's-Hertogenbosch, Netherlands. Kallol Karl Guha has been the CEO of the Dutch company since 2013. | Investment Banks/Brokers | Director/Board Member | |
| Stichting Arq P Notes | Investment Trusts/Mutual Funds | Director/Board Member | |
| VAN LANSCHOT KEMPEN N.V | Investment Managers | Director/Board Member | |
Northern California Planned Giving Council
 Northern California Planned Giving Council Miscellaneous Commercial ServicesCommercial Services The Northern California Planned Giving Council is an organization that provides educational programs on planned giving. The non-profit company is based in Windsor, CA. Its members include major gifts officers and planned giving officers. The council is affiliated with the National Association of Charitable Gift Planners and has been providing educational programs for over 26 years. The council's annual masters program is named in honor of Heidi Strassburger, a long-time member and past president of the council who passed away prematurely. | Miscellaneous Commercial Services | Director/Board Member | |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| University of California, Davis | College/University | Undergraduate Degree | |
| Golden Gate University | College/University | Masters Business Admin | |
| Karolinska Institutet | College/University | Doctorate Degree | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
| Björks Matematik o Mera AB | Director/Board Member | ||
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman | |
| California State University-East Bay | College/University | Graduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| California State University-Sacramento | College/University | Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Uppsala | College/University | Corporate Officer/Principal | |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Chalmers University of Technology | College/University | Director/Board Member | |
| ROCKET PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| Nefarma | Director/Board Member | ||
| Harvard College | College/University | Undergraduate Degree | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Chairman | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
SVB Capital
 SVB Capital Investment ManagersFinance SVB Capital Management LLC (SVB Capital Management) is a venture capital arm of SVB Financial Group founded in 2000 by Aaron Gershenberg and Gregory Becker. The firm is headquartered in Santa Clara, California. | Investment Managers | Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree | |
| Thunderbird School of Global Management | College/University | Masters Business Admin | |
| FIRST REPUBLIC BANK | Regional Banks | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 18 |
| Suecia | 13 |
| Países Bajos | 10 |
| Suiza | 5 |
| Alemania | 4 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 13 |
| Finance | 7 |
| Miscellaneous | 3 |
| Commercial Services | 3 |
Operativa
| Director/Board Member | 158 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 38 |
| Founder | 18 |
| Chairman | 15 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Martijn Kleijwegt | 33 |
| Rémi Droller | 29 |
| Berndt A. E. Modig | 23 |
| Lorraine Hariton | 23 |
| Johannes G. C. P. Schikan | 22 |
| Viviane Monges | 21 |
| Dave L. Anderson | 19 |
| David Meeker | 19 |
| Richard Gaster | 17 |
| Robert Glassman | 16 |
| Margareta Elisabeth Björk | 12 |
| Jochen Knolle | 11 |
| Michael Rome | 9 |
| Joan Schmidt | 7 |
| Anne Marie de Jonge Schuermans | 6 |
- Bolsa de valores
- Insiders
- Anna Nijdam
- Conexiones Empresas